Inicio › Enfermedades autoinmunes › Florida
Ensayos clínicos de Enfermedades autoinmunes en Florida
20 estudios sobre Enfermedades autoinmunes buscan participantes en Florida.
Ciudades en Florida
- Jacksonville6 estudios
- Miami6 estudios
- Orlando4 estudios
- Tampa4 estudios
- St. Petersburg3 estudios
- Gainesville3 estudios
Texto oficial del estudio (inglés)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Res Of W Florida, Clearwater
- Clinical Research of West Florida Inc, Tampa
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07621809Secukinumab Open Label Roll-over Extension Protocol
- Rheumatology Associates of South Florida, Boca Raton
- FL Medical Clinic Orlando Health, Zephyrhills
ReclutandoFase 4
Edades de 6 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT04638647A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
ReclutandoFase 2
Edades de 18 a 60 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07541287Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Miami Clinical Research, Miami
- GCP Clinical Research, Tampa
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07513181RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
- Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg
ReclutandoFase 2/3
Edades de 6 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- University of Miami Hospital, Miami
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07182227A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Mayo Clinic, Jacksonville
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06121297RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 ago 2026 · NCT06328777Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 17 ago 2026 · NCT06858319RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic Florida, Jacksonville
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 13 ago 2026 · NCT06359041A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Southern Florida, St. Petersburg
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-100, Miami
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1006, Clearwater
- Site Number - 1037, Ormond Beach
- Site Number - 1002, Port Charlotte
- y 2 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Miami, Miami
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Florida Shands Medical Center, Gainesville
- Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
- University of Miami (peds), Miami
- y 6 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
ReclutandoFase 1
Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 feb 2026 · NCT06626919Rheumatology Diet Study
- UCF Health Clinics, Orlando
ReclutandoEstudio observacional
Edades de 18 a 65 · Todos los sexos · Actualizado el 6 dic 2024 · NCT06339957De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.